Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117324) titled 'Efficacy and Mechanism of Omalizumab in Different Immunological Subtypes of Chronic Spontaneous Urticaria' on Jan. 22.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Chronic Spontaneous Urticaria
Intervention:
Non-disease-controlled study participants:Collect an additional tube of the patients peripheral blood for single-cell sequencing, in addition to the routine blood draw
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-22
Target Sample Size: Non-disease-controlled study participant...